Cargando…

The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature

Background: The human anti-IL-6 receptor antibody tocilizumab (TCZ) has been approved for the treatment of rheumatoid arthritis (RA) and giant cell arteritis (GCA). It is observed that CRP levels drop quickly after starting TCZ treatment. This may lead to misinterpretation of laboratory results when...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berman, Mark, Ben-Ami, Ronen, Berliner, Shlomo, Anouk, Marina, Kaufman, Ilana, Broyde, Adi, Borok, Sara, Elkayam, Ori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003879/ https://www.ncbi.nlm.nih.gov/pubmed/33804790 http://dx.doi.org/10.3390/life11030258

Ejemplares similares

Reduced C-reactive protein level at hospital admission in patients treated with Tocilizumab – An attention may be required
por: Berman, Mark, et al.
Publicado: (2023)

Idiopathic Eosinophilic Vasculitis: Case Presentation and Literature Review
por: Broyde, Adi, et al.
Publicado: (2023)

Identification of serious, unpredictable adverse events with tocilizumab
Publicado: (2020)

Sepsis Related Mortality Associated with an Inflammatory Burst in Patients Admitting to the Department of Internal Medicine with Apparently Normal C-Reactive Protein Concentration
por: Meilik, Ronnie, et al.
Publicado: (2022)

Cocaine-Induced Vasculitis
por: Berman, Mark, et al.
Publicado: (2016)

Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab
por: Furer, Victoria, et al.
Publicado: (2022)

Comparison of Different Anthropometric Measurements and Inflammatory Biomarkers
por: Arbel, Yaron, et al.
Publicado: (2012)

Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study
por: Rogowski, Ori, et al.
Publicado: (2010)

C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department
por: Paran, Yael, et al.
Publicado: (2009)

Bilateral Neuroretinitis and a Unilateral Superior Hemivein Occlusion with Frosted Branch Angiitis Pattern Presenting Simultaneously in Behçet's Disease
por: Schwartz, Roy, et al.
Publicado: (2016)

A second C-reactive protein (CRP) test to detect inflammatory burst in patients with acute bacterial infections presenting with a first relatively low CRP
por: Goldberg, Ilan, et al.
Publicado: (2020)

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
por: Rubio-Rivas, Manuel, et al.
Publicado: (2021)

Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection
por: Rabie, Al Shaimaa Ibrahim, et al.
Publicado: (2023)

Platelet Counts and Platelet Activation Markers in Obese Subjects
por: Samocha-Bonet, Dorit, et al.
Publicado: (2008)

Safety and Efficacy of Vaccination Against Influenza in Patients With Rheumatoid Arthritis
por: Elkayam, Ori
Publicado: (2006)

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population
por: Berman, Julia, et al.
Publicado: (2021)

Simvastatin Induces Apoptosis of Fibroblast-Like Synoviocytes
por: Litinsky, Ira, et al.
Publicado: (2009)

564. Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19
por: Colgrove, Robert, et al.
Publicado: (2020)

Early Detection of Inflammation-Prone STEMI Patients Using the CRP Troponin Test (CTT)
por: Brzezinski, Rafael Y., et al.
Publicado: (2022)

Heart Valve Surgery in Antiphospholipid Syndrome Patients—Morbidity and Mortality
por: Eviatar, Tali, et al.
Publicado: (2023)

The effect of two iso-caloric meals containing equal amounts of fats with a different fat composition on the inflammatory and metabolic markers in apparently healthy volunteers
por: Raz, Olga, et al.
Publicado: (2013)

Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
por: Elalouf, Ofir, et al.
Publicado: (2015)

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
por: Furer, Victoria, et al.
Publicado: (2023)

The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome
por: Steinvil, Arie, et al.
Publicado: (2010)

Elevated resting heart rate is associated with the metabolic syndrome
por: Rogowski, Ori, et al.
Publicado: (2009)

Tocilizumab for refractory morphea in adults: A case series
por: Lonowski, Sarah, et al.
Publicado: (2022)

28. Acute gout with normal inflammatory markers in a seropositive rheumatoid arthritis on longstanding tocilizumab.
por: Levasseur, Kirsty, et al.
Publicado: (2017)

Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM
por: Klopfenstein, Timothée, et al.
Publicado: (2022)

Differentiating between bacterial and viral infections by estimated CRP velocity
por: Largman-Chalamish, Michal, et al.
Publicado: (2022)

Normoferremia in Patients with Acute Bacterial Infections—A Hitherto Unexplored Field of the Dichotomy between CRP and Ferritin Expression in Patients with Hyper Inflammation and Failure to Increase Ferritin
por: Levinson, Tal, et al.
Publicado: (2023)

Assessment of Candida auris Response to Antifungal Drugs Using Time–Kill Assays and an Animal Model
por: Ben-Ami, Ronen, et al.
Publicado: (2017)

Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study
por: Olewicz-Gawlik, Anna, et al.
Publicado: (2021)

‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply
por: Broman, Niklas, et al.
Publicado: (2022)

Septic patients presenting with apparently normal C-reactive protein: A point of caution for the ER physician
por: Wasserman, Asaf, et al.
Publicado: (2019)

Beneficial of adding Tocilizumab to standard care in critical forms of Covid-19 pneumonia: Study on paired series
por: Trif, Ahlem, et al.
Publicado: (2022)

Tocilizumab for relapsing and remitting giant cell arteritis: a case series
por: Saha, Pratyasha, et al.
Publicado: (2022)

Tocilizumab for juvenile idiopathic arthritis: a single-center case series
por: Yazılıtaş, Fatma, et al.
Publicado: (2020)

The Changing Face of Spondyloarthropathies Under TNF α Blockade
por: Elkayam, Ori, et al.
Publicado: (2008)

Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders
por: Ablin, Jacob N., et al.
Publicado: (2016)

Anti-SARS-CoV-2 antibody levels after four BNT162b2 vaccine doses among health-care workers
por: Saiag, Esther, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f5uajocv36k8u3kl6hi932tfk0